A pilot study to determine the effect of dietary intervention on novel biomarkers of breast cancer risk

2012 ◽  
Author(s):  
Aedin Cassidy
2020 ◽  
Vol 182 (2) ◽  
pp. 451-463 ◽  
Author(s):  
Anna H. Wu ◽  
Chiuchen Tseng ◽  
Cheryl Vigen ◽  
Yang Yu ◽  
Wendy Cozen ◽  
...  

2015 ◽  
Vol 8 (10) ◽  
pp. 912-921 ◽  
Author(s):  
Carol J. Fabian ◽  
Bruce F. Kimler ◽  
Teresa A. Phillips ◽  
Jessica A. Box ◽  
Amy L. Kreutzjans ◽  
...  

2014 ◽  
Vol 99 (2) ◽  
pp. 625-632 ◽  
Author(s):  
Adana A. Llanos ◽  
Juan Peng ◽  
Michael L. Pennell ◽  
Jessica L. Krok ◽  
Mara Z. Vitolins ◽  
...  

Context: Breast cancer risk among postmenopausal women increases as body mass index increases. Practical preventive methods to reduce risk of breast cancer are lacking. Few studies have investigated the effects of carotenoids and isoflavones on circulating adipokines in postmenopausal women. Objective: The aim was to examine the effects of lycopene- and isoflavone-rich diets on serum adipokines. Design: This was a 26-week, two-arm, longitudinal crossover trial. Setting: Participants were recruited from clinics at The Ohio State University Comprehensive Cancer Center. Participants: Seventy postmenopausal women at increased breast cancer risk participated in the study. The mean age and body mass index of participants was 57.2 years and 30.0 kg/m2, respectively; the study was comprised of 81.4% whites. Interventions: The interventions included 10 weeks of consumption of a tomato-based diet (≥25 mg lycopene daily) and 10 weeks of consumption of a soy-based diet (≥40 g of soy protein daily), with a 2-week washout in between. Main Outcome Measures: Changes in serum adiponectin, leptin, and the adiponectin to leptin ratio were examined for each intervention through linear mixed models, with ratio estimates corresponding to postintervention adipokine concentrations relative to preintervention concentrations. Results: After the tomato intervention, among all women, adiponectin concentration increased (ratio 1.09, 95% confidence interval (CI) 1.00–1.18), with a stronger effect observed among nonobese women (ratio 1.13, 95% CI 1.02–1.25). After the soy intervention, adiponectin decreased overall (ratio 0.91, 95% CI 0.84–0.97), with a larger reduction observed among nonobese women (ratio 0.89, 95% CI 0.81–0.98). Overall, no significant changes in leptin or the adiponectin to leptin ratio were observed after either intervention. Conclusions: Increasing dietary consumption of tomato-based foods may beneficially increase serum adiponectin concentrations among postmenopausal women at increased breast cancer risk, especially those who are not obese. Additional studies are essential to confirm these effects and to elucidate the specific mechanisms that may make phytonutrients found in tomatoes practical as breast cancer chemopreventive agents.


2012 ◽  
Author(s):  
Ningqi Hou ◽  
Antony Gakwaya ◽  
Paul Ndom ◽  
Oladosu Ojengbede ◽  
Olufunmilayo I. Olopade ◽  
...  

2019 ◽  
Vol 12 (10) ◽  
pp. 711-720 ◽  
Author(s):  
Carol J. Fabian ◽  
Lauren Nye ◽  
Kandy R. Powers ◽  
Jennifer L. Nydegger ◽  
Amy L. Kreutzjans ◽  
...  

2010 ◽  
Vol 62 (6) ◽  
pp. 759-764 ◽  
Author(s):  
Mylène Aubertin-Leheudre ◽  
Anja Koskela ◽  
Adile Samaletdin ◽  
Herman Adlercreutz

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 10539-10539
Author(s):  
R. V. Raghupathy ◽  
C. W. Seidler ◽  
S. Emani ◽  
J. Rooney

10539 Background: Prior prospective cohort studies have provided conflicting data regarding lipid levels as a breast cancer risk factor. These studies were either designed to study cardiovascular diseases or included a small number of incident cases. This retrospective pilot study compared the lipid profiles of breast cancer patients to a normal cohort obtained from a large community based HMO database. Methods: Fallon Clinic automated outpatient billing and laboratory databases were used to identify patients with breast cancer (ICD9–174.9) and retrieve average lipid profiles at least two years prior to the first identified diagnosis date. The outpatient billing record of a central Massachusetts HMO was used to randomly generate a control group without an ICD9 diagnosis of breast cancer. Patients were classified into two groups based on age to approximate menopausal state (pre menopausal <50 yr, post menopausal ≥50 yr). T-tests were conducted to compare the total cholesterol, LDL, HDL and triglycerides of the two groups. Results: See table. Conclusions: In the pre-menopausal population, total cholesterol and LDL were significantly higher in the breast cancer group. In the post-menopausal group, triglycerides were higher and HDL lower. Though the HDL association is in concurrence with two large prior studies, other associations have not been demonstrated. An average of fasting levels obtained more than two years before diagnosis eliminates the lipid profile response to meals, variability in isolated values and influence of pre-clinical cancer on the data. However, the patients have not been matched for other breast cancer risk factors or variable menstrual phase while obtaining samples in the pre-menopausal population. [Table: see text] No significant financial relationships to disclose.


2017 ◽  
Vol 35 (3) ◽  
pp. 249-259 ◽  
Author(s):  
Jennifer K. Bernat ◽  
Stephanie E. Hullmann ◽  
Glenn G. Sparks

Sign in / Sign up

Export Citation Format

Share Document